MedPath

The COOKER-BLADDER Trial

Not Applicable
Recruiting
Conditions
Urinary Bladder Diseases
Diet, Healthy
Oncogenesis
Registration Number
NCT05643963
Lead Sponsor
Roland Seiler-Blarer
Brief Summary

The goal of this interventional study is to test the influence of food intake with characteristics of the urinary bladder. The main questions it aims to answer are:

* How does food intake modify the characteristics of urothelial cells?

* Does change of specific diet regimes influence biomarker characteristics in urine? Participants will follow specific diet regime for a given time period. After completion of this period biomarker assessment is performed. Thereafter the participants follow an opposite diet regime for the same time period with identical biomarker assessment at the end.

Biomarkers within the participants and between the diet regimes will be compared to investigate the influence of food intake on the urinary bladder.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • no daily medication
  • no ongoing medical treatment
Exclusion Criteria
  • Chronic disease
  • Regular medication
  • Not willing to follow diet instructions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Change in molecular profile of urothelial cells12 weeks

After the 12 week diet period (protective and non-protective), cells voided in urine will be sampled and examined.

Secondary Outcome Measures
NameTimeMethod
Change in multiplex cytokine levels in voided urine12 weeks

After the 12 week diet period (protective and non-protective), supernatant in voided urine will be used for further examination

DNA sequences in urinary microbiome12 weeks

After the 12 week diet period (protective and non-protective), DNA sequencing on urinary microbiome in voided urine will be performed and compared between the different dietary regimens.

Change of BMI12 weeks

After the 12 week diet period (protective and non-protective) BMI will be assessed.

Change of heart rate12 weeks

After the 12 week diet period (protective and non-protective), heart rate will be assessed.

Change of blood pressure12 weeks

After the 12 week diet period (protective and non-protective), systolic and diastolic blood pressure will be assessed.

Change of health status12 weeks

After the 12 week diet period (protective and non-protective), health status will be assessed using the Short Form 36 (SF-36) questionaire.

The possible score ranges from 0 to 100 points, with 0 points representing the greatest possible health limitation, and 100 points representing no health limitation.

Trial Locations

Locations (2)

Department of Urology, Spitalzentrum Biel

🇨🇭

Biel/Bienne, BE, Switzerland

Roland Seiler

🇨🇭

Biel, Switzerland

Department of Urology, Spitalzentrum Biel
🇨🇭Biel/Bienne, BE, Switzerland
Roland Seiler-Blarer
Contact
+41 32 324 32 06
Roland.Seiler-Blarer@szb-chb.ch
Martina Schneider
Contact
+41 32 324 32 17
Martina.Schneider@szb-chb.ch
Roland Seiler Blarer
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.